CDXS compared with ETON: revenue, margins and what each company keeps, and the suppliers and customers both name

CDXSCodexis, Inc.

Mkt capRevenueRevenue

ETONEton Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

CDXSCodexis, Inc.

ETONEton Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

CDXS: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only CDXS 17

—One customerunlistedcustomer

—Customers that each individually contributed 10% or more of total revenueunlistedcustomer

MRKMerckcustomer

PFEPfizercustomer

13 more · CDXS chain ›

Shared 0

No shared counterparties.

Only ETON 13

—AnovoRxunlistedcustomer

TEVATeva Pharmaceuticals USAsupplier

—Ipsen Biopharmaceuticalsunlistedsupplier

—

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

AMMTeK

unlistedsupplier

9 more · ETON chain ›

Price

rebased to 0%

CDXS, solidETON, dashed

CDXSCodexis, Inc.

1.19▼−2.41%· post 1.20

Mkt cap$108.4MRevenue$15MQ2 FY26Revenue$59MFY24

ETONEton Pharmaceuticals, Inc.

52.20▼−2.75%· post 52.20

ClosedOct 30 '26

Mkt cap$1.5BRevenue$38MQ2 FY26Revenue$80MFY25

Compare

ClosedOct 30 '26

CDXSCodexis, Inc.

ETONEton Pharmaceuticals, Inc.

1.19▼−2.41%post 1.20

Price

52.20▼−2.75%post 52.20

$108.4M

Mkt cap

$1.5B

Q2 FY26$15M

Revenue

$38MQ2 FY26

FY24$59M

Revenue

$80MFY25

CDXS1.19▼−2.41%vsETON52.20▼−2.75%ClosedOct 30 '26